CytomX Therapeutics, Inc.
ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF

Abstract:

The invention relates generally to activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.